Emile, S. H.
Garoufalia, Z.
Mavrantonis, S.
Rogers, P.
Barsom, S. H.
Horesh, N.
Gefen, R.
Wexner, S. D.
Article History
Received: 27 February 2024
Accepted: 30 August 2024
First Online: 1 October 2024
Declarations
:
: None of the authors reports to any relevant financial or personal disclosures. Dr. Wexner is a consultant for ARC/Corvus, Baxter, Becton, Dickinson and Co, GI Supply, Glaxo Smith Kline, ICON Clinical Research Ltd, Intuitive Surgical, Leading Biosciences/PalisadeBio, Livsmed, Medtronic, Olympus, OstomyCure, Stryker, Takeda, Virtual Ports; is a member of the Data Safety Monitoring Board of JSR/WCG/ACI (chair), Polypoid (chair), and Boomerang; and receives royalties from Intuitive Surgical Karl Storz Endoscopy America Inc., Medtronic, and Unique Surgical Solutions, LLC.